SGCG gene

GPTKB entity

Statements (110)
Predicate Object
gptkbp:instance_of gptkb:DNA
gptkbp:advances contributed to understanding of muscular dystrophies
gptkbp:alias gptkb:sarcoglycan_gamma
gptkbp:alleles multiple variants
gptkbp:anatomy skeletal muscle
gptkbp:application study of muscular dystrophies
gptkbp:associated_with gptkb:muscular_dystrophy
fatigue
exercise intolerance
genetic counseling
muscle atrophy
diagnostic imaging
immunohistochemistry
muscle hypertrophy
muscle cramps
myalgia
biopsy findings
dystrophin-associated glycoprotein complex
family history of muscular dystrophy
increased creatine kinase levels
limb-girdle muscular dystrophy 2 C
gptkbp:biomarker_potential under investigation for disease progression
gptkbp:breeding_range 13q12.3
gptkbp:character_traits muscle weakness
respiratory issues
joint contractures
cardiac involvement
progressive muscle wasting
gptkbp:clinical_phenotype variable expressivity
gptkbp:clinical_trial ongoing
pathogenic mutations
ongoing for treatment options
focused on treatment efficacy
important for muscle function
ongoing in Phase I/ II
gptkbp:clinical_use requires multidisciplinary approach
gptkbp:code gptkb:sarcoglycan_gamma
gptkbp:collaborations international studies ongoing
gptkbp:diagnosis available for detection of mutations
gptkbp:discovery_year gptkb:1995
gptkbp:disease_mechanism disruption of muscle membrane integrity
gptkbp:diseases gptkb:Cardiology
gptkb:muscular_dystrophy
limb-girdle muscular dystrophy type 2 C
linked to LGMD2 C
gptkbp:ecological_role structural component of muscle
gptkbp:financial_support available for affected individuals
gptkbp:function encodes a protein
muscle cell membrane stability
gptkbp:funding supported by various organizations
gptkbp:genetic_map mapped to human genome
gptkbp:genetic_mapping completed in several studies
gptkbp:genetic_screening recommended for at-risk populations
gptkbp:genetic_studies available
loss of function
deletion
insertion
point mutation
recommended for affected families
available for mutations
nonsense mutations
varies among populations
gain of function
disruption of protein function
causes muscular dystrophy
gptkbp:genetic_variants identified in clinical studies
https://www.w3.org/2000/01/rdf-schema#label SGCG gene
gptkbp:is_expressed_in skeletal muscle
high in muscle tissue
gptkbp:located_in human chromosome 13
gptkbp:location chromosome 13
gptkbp:mutation_analysis performed in affected families
gptkbp:nutritional_value cell membrane stabilization
contains transmembrane domains
interacts with other sarcoglycans
involved in complex formation with other proteins
localized to the sarcolemma
sarcoglycan family
gptkbp:orthologs SGCG in other species
gptkbp:pathogenic_variants identified in patients
gptkbp:pathway muscle contraction
muscle development
gptkbp:promoter muscle structure
SGCG
part of the dystrophin-associated glycoprotein complex
gptkbp:protein_length approximately 400 amino acids
gptkbp:publication numerous studies published
gptkbp:regulatory_compliance regulated by transcription factors
gptkbp:related_to gptkb:sarcoglycan_complex
gptkbp:research gene therapy studies
gptkbp:research_areas gptkb:Genetics
aims to restore normal function
focused on restoring function
gptkbp:research_focus therapeutic strategies
disease mechanisms
protein interactions
gene therapy approaches
mutation analysis
gene therapy for LGMD
gptkbp:seed_dispersal protein-coding gene
gptkbp:therapeutic_strategies include gene replacement therapy
gptkbp:therapeutic_targets potential for gene editing
gptkbp:transcription_start_site located upstream of coding region
gptkbp:treatment gptkb:gene_therapy
physical therapy
supportive care
improved with early intervention
gptkbp:weight about 45 k Da
gptkbp:bfsParent gptkb:sarcoglycan_complex
gptkbp:bfsLayer 7